Forest Pays Up To $10M In MDL Over Celexa, Lexapro

Law360, San Francisco (March 14, 2014, 6:33 PM EDT) -- Forest Laboratories Inc. agreed to pay between $7.7 million and $10.4 million to settle multidistrict litigation accusing the drugmaker of misleading Missouri parents into buying Celexa and Lexapro for children although the drugs were only approved for adults, according to papers filed in Massachusetts federal court Thursday.

The plaintiffs urged U.S. District Court Judge Nathaniel M. Gorton to certify a settling class of parents in Missouri and appoint Pendley Baudin & Coffin LLP and Baum Hedlund Aristei & Goldman PC as the settlement counsel. They also asked the...
To view the full article, register now.